James Koukios spoke to Anti-Corruption Report for an article that covers how Cardinal Health’s SEC settlement that cost them $8.8 million due to its Chinese subsidiary violating the FCPA’s internal controls and recordkeeping provisions.
“The [cease-and-desist] order suggests to me that Cardinal Health was pretty thoughtful in how it approached these issues,” James said, adding that the termination of most of the other marketing accounts “suggests that Cardinal may have done at least some pre- and post-acquisition due diligence and integration work that resulted in red flags for other arrangements but provided some confidence that this arrangement could go forward.”
Read the full article (subscription required).